Cogent Biosciences (COGT) News Today $12.94 -0.14 (-1.07%) Closing price 09/4/2025 04:00 PM EasternExtended Trading$13.20 +0.26 (+2.02%) As of 09/4/2025 06:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock COGT Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Cogent Biosciences, Inc. $COGT Shares Sold by Redmile Group LLCSeptember 4 at 7:28 AM | marketbeat.comVestal Point Capital LP Invests $17.97 Million in Cogent Biosciences, Inc. $COGTSeptember 4 at 7:17 AM | marketbeat.comRaymond James Initiates Coverage of Cogent Biosciences (COGT) with Strong Buy RecommendationSeptember 4 at 4:09 AM | msn.comRussell Investments Group Ltd. Buys 29,669 Shares of Cogent Biosciences, Inc. $COGTSeptember 4 at 3:26 AM | marketbeat.comCogent Biosciences, Inc. (COGT) Presents At Citi's Biopharma Back To School Conference TranscriptSeptember 3 at 4:06 PM | seekingalpha.comCogent Biosciences, Inc. $COGT Shares Bought by Paradigm Biocapital Advisors LPSeptember 2 at 7:09 AM | marketbeat.comWellington Management Group LLP Trims Stock Holdings in Cogent Biosciences, Inc. $COGTSeptember 2 at 3:58 AM | marketbeat.comNuveen LLC Makes New $1.40 Million Investment in Cogent Biosciences, Inc. $COGTSeptember 2 at 3:31 AM | marketbeat.comCogent Biosciences, Inc. $COGT Position Trimmed by Walleye Capital LLCAugust 30, 2025 | marketbeat.comCogent Biosciences, Inc. (NASDAQ:COGT) Receives Average Rating of "Moderate Buy" from BrokeragesAugust 29, 2025 | marketbeat.comCogent Biosciences, Inc. (NASDAQ:COGT) Given Consensus Recommendation of "Moderate Buy" by BrokeragesAugust 29, 2025 | marketbeat.comSwiss National Bank Has $833,000 Position in Cogent Biosciences, Inc. $COGTAugust 29, 2025 | marketbeat.comVanguard Group Inc. Has $36.29 Million Stock Position in Cogent Biosciences, Inc. $COGTAugust 29, 2025 | marketbeat.comCogent Biosciences (NASDAQ:COGT) Price Target Raised to $20.00August 27, 2025 | marketbeat.comEntryPoint Capital LLC Lowers Stock Holdings in Cogent Biosciences, Inc. $COGTAugust 27, 2025 | marketbeat.comCogent Biosciences: Moving ForwardAugust 26, 2025 | seekingalpha.comCogent Biosciences Announces Participation in the Citi Biopharma ConferenceAugust 26, 2025 | globenewswire.comGuggenheim Boosts Cogent Biosciences (NASDAQ:COGT) Price Target to $20.00August 26, 2025 | americanbankingnews.comAlgert Global LLC Has $3.16 Million Stock Position in Cogent Biosciences, Inc. $COGTAugust 23, 2025 | marketbeat.comCogent Biosciences, Inc. $COGT Shares Acquired by Fox Run Management L.L.C.August 22, 2025 | marketbeat.comXTX Topco Ltd Cuts Stake in Cogent Biosciences, Inc. (NASDAQ:COGT)August 16, 2025 | marketbeat.comKnott David M Jr Takes $1.28 Million Position in Cogent Biosciences, Inc. (NASDAQ:COGT)August 12, 2025 | marketbeat.comWedbush Has Pessimistic Outlook of COGT FY2025 EarningsAugust 9, 2025 | marketbeat.comHC Wainwright Issues Optimistic Outlook for COGT EarningsAugust 9, 2025 | marketbeat.comQ3 Earnings Estimate for COGT Issued By Leerink PartnrsAugust 9, 2025 | marketbeat.comJPMorgan Chase & Co. Increases Cogent Biosciences (NASDAQ:COGT) Price Target to $30.00August 8, 2025 | marketbeat.comLeerink Partners Sticks to Their Buy Rating for Cogent Biosciences (COGT)August 8, 2025 | theglobeandmail.comQ3 EPS Estimate for Cogent Biosciences Decreased by AnalystAugust 8, 2025 | marketbeat.comCogent Biosciences (COGT) Gets a Hold from Robert W. BairdAugust 8, 2025 | theglobeandmail.comHC Wainwright Has Lowered Expectations for Cogent Biosciences (NASDAQ:COGT) Stock PriceAugust 7, 2025 | marketbeat.comCogent Biosciences (NASDAQ:COGT) Posts Earnings Results, Beats Estimates By $0.01 EPSAugust 6, 2025 | marketbeat.comCogent Biosciences price target lowered to $21 from $22 at H.C. WainwrightAugust 6, 2025 | msn.comCogent Biosciences Reports Recent Business Highlights and Second Quarter 2025 Financial ResultsAugust 5, 2025 | globenewswire.comCogent Biosciences, Inc. (NASDAQ:COGT) Given Consensus Recommendation of "Moderate Buy" by AnalystsAugust 3, 2025 | marketbeat.comNeedham Reaffirms Their Hold Rating on Cogent Biosciences (COGT)August 1, 2025 | theglobeandmail.comScotiabank Sticks to Its Buy Rating for Cogent Biosciences (COGT)August 1, 2025 | theglobeandmail.comY Intercept Hong Kong Ltd Sells 31,538 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT)July 31, 2025 | marketbeat.comCogent Biosciences (COGT) Expected to Announce Earnings on TuesdayJuly 30, 2025 | marketbeat.com2 Biotech and 2 Tech Stocks Insiders Are Scooping Up NowJuly 23, 2025 | 247wallst.comReadystate Asset Management LP Has $2.10 Million Stake in Cogent Biosciences, Inc. (NASDAQ:COGT)July 23, 2025 | marketbeat.comCitigroup Issues Positive Forecast for Cogent Biosciences (NASDAQ:COGT) Stock PriceJuly 19, 2025 | marketbeat.comCogent Biosciences (NASDAQ:COGT) Reaches New 12-Month High - Here's What HappenedJuly 19, 2025 | marketbeat.comLeerink Partnrs Has Pessimistic View of COGT Q2 EarningsJuly 17, 2025 | marketbeat.comJefferies Raises Cogent Biosciences (COGT) PT, Keeps Buy RatingJuly 16, 2025 | msn.comWhat is Leerink Partnrs' Estimate for COGT FY2027 Earnings?July 16, 2025 | marketbeat.comInsider Buying: Cogent Biosciences, Inc. (NASDAQ:COGT) Director Acquires 2,777,777 Shares of StockJuly 15, 2025 | insidertrades.comCogent Biosciences, Inc. (NASDAQ:COGT) Director Fairmount Funds Management Llc Acquires 2,777,777 SharesJuly 14, 2025 | marketbeat.comCogent Biosciences Announces Closing of Upsized Public Offering of ...July 12, 2025 | morningstar.comMCogent Biosciences Announces Closing of Upsized Public Offering of Shares of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional SharesJuly 10, 2025 | globenewswire.comCogent Biosciences (NASDAQ:COGT) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst SaysJuly 10, 2025 | marketbeat.com Get Cogent Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for COGT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. COGT Media Mentions By Week COGT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. COGT News Sentiment▼1.300.70▲Average Medical News Sentiment COGT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. COGT Articles This Week▼134▲COGT Articles Average Week Get the Latest News and Ratings for COGT and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Cogent Biosciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Merus News CRISPR Therapeutics News TG Therapeutics News ACADIA Pharmaceuticals News Krystal Biotech News Cytokinetics News Jyong Biotech News ADMA Biologics News Vaxcyte News Ascentage Pharma Group International News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:COGT) was last updated on 9/5/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cogent Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cogent Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
